Celgene Corporation (NASDAQ:CELG) today announced that data from more than 160 abstracts, including 39 oral presentations, evaluating Celgene investigational products and investigational uses of marketed products will be presented at the 56th American Society of Hematology Annual Meeting between Dec. 6-9 in San Francisco, Calif.
Help employers find you! Check out all the jobs and post your resume.
